Optimization and Quest of HPMC loaded Stavudine Controlled Release Dosage Development by Central Composite Design utilizing Reduced Factorial Screening Technique
DOI:
https://doi.org/10.1590/s2175-97902022e201144Keywords:
Stavudine controlled release tablet, Optimization technique, Screening technique, Reduced factorial design, Mathematical modelingAbstract
The current research focused on screening and finding the significant independent variables in stavudine loaded tablet, followed by optimizing the best formulation using central composite design. The objective of the study to develop stavudine loaded controlled release tablet utilizing reduced factorial design, followed by optimization technique as well as characterization of prepared tablets. Preliminary trial batches were prepared using different grades of hydroxypropyl methylcellulose. The resolution-IV reduced factorial design was selected to screen the significant independent variables in the dosage form design. A total number of eight runs were prepared and responses were recorded. The signified factors identified by half-normal and Pareto chart. The prepared tablets are evaluated for various physiochemical characterizations. Three dependent responses such as hardness, dissolution at 6 hour and 12 hours are considered in optimization process. Later on, drug-polymer interaction study was carried out. The principal of the study design based on finding the best formulation with prefixed set parameter values utilizing the concept of screening technique. It observed that HPMC K15M (57.18 %), HPMC K100 (66.32 %) and PVP K30 (7.97 %) as best composition in a formulation batch would fulfill the predetermined parameter with specific values.
Downloads
References
Attia AK, Abdel-Moety MM, Abdel-Hamid SG. Thermal analysis study of antihypertensive drug doxazosin mesilate. Arab J Chem. 2017;10:S334-8.
Zerit (Stavudine). Available from: Available from: https://www.accessdata. fda.gov/drugsatfda_docs/label/2002/20412S017.pdf [cited 2021 April 1].
» https://www.accessdata. fda.gov/drugsatfda_docs/label/2002/20412S017.pdf
Arinkoola AO, Ogbe DO. Examination of experimental designs and response surface methods for uncertainty analysis of production forecast: A Niger Delta case study. J Pet Eng. 2015;2015:16.
Aslani A, Sharifian T. Formulation, characterization and physicochemical evaluation of amoxicillin effervescent tablets. Adv Biomed Res. 2014;3:209.
Attia AK, Abdel-Moety MM, Abdel-Hamid SG. Thermal analysis study of antihypertensive drug doxazosin mesilate. Arab J Chem. 2017;10(Supplement 1):S334-8.
Aziz DE, Abdelbary AA, Elassasy AI. Implementing central composite design for developing transdermal diacerein- loaded niosomes: ex vivo permeation and in vivo deposition. Curr Drug Deliv. 2018;15(9):1330-42.
Baker TB, Smith SS, Bolt DM, Loh WY, Mermelstein R, Fiore MC, et al. Implementing clinical research using factorial designs: a primer. Behav Ther. 2017;48(4):567-80.
Baranov A, Muzyko E. Valuation of compound real options for investments in innovative projects in pharmaceutical industry. Procedia Econ. 2015;27:116-25.
Cheng L, Li T, Dong L, Wang X, Huo Q, Wang H, et al. Design and evaluation of bilayer pump tablet of flurbiprofen solid dispersion for zero-order controlled delivery. J Pharm Sci. 2018;107(5):1434-42.
Dokoumetzidis A, Kalantzi L, Fotaki N. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models. Expert Opin Drug Metab Toxicol. 2007;3(4):491-505.
Durakovic B. Design of experiments application, concepts, examples: State of the art. Period Eng Nat Sci. 2017;5(3):421-39.
El-Helaly SN, Habib BA, El-Rahman M K. Resolution V fractional factorial design for screening of factors affecting weakly basic drugs liposomal systems. Eur J Pharm Sci . 2018;119:249-58.
Giaccotto C, Golec J, Vernon J. New estimates of the cost of capital for pharmaceutical firms. J Corp Finan. 2011;17(3):526-40.
Gill P, Moghadam TT, Ranjbar B. Differential scanning calorimetry techniques: applications in biology and nanoscience. J Biomol Tech. 2010;21(4):167-93.
Hardikar S, Bhosale A. Formulation and evaluation of gastro retentive tablets of clarithromycin prepared by using novel polymer blend. Bull Fac Pharm Cairo Univ. 2018;56(2):147-57.
Hasniyati MR, Zuhailawati H, Ramakrishnan S. A statistical prediction of multiple responses using overlaid contour plot on hydroxyapatite coated magnesium via cold spray deposition. Procedia Chem. 2016;19:181-8.
Hejaz H A, Karaman R. Drug overview. Commonly used drug. In: Rafik Karaman Ed. New York: Nova Science Publishers. 2015.; pp. 1-40.
Hooda A, Nanda A, Jain M, Kumar V, Rathee P. Optimization and evaluation of gastroretentive ranitidine HCl microspheres by using design expert software. Int J Biol Macromol. 2012;51(5):691-700.
Huang J, Wigent RJ, Schwartz JB. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend. J Pharm Sci . 2008;97(1):251-62.
Jaynes J, Ding X, Xu H, Wong WK, Ho CM. Application of fractional factorial designs to study drug combinations. Sta t Med. 2013;32(2):307-18.
Sah AK, Suresh PK. Loteprednol etabonate nanoparticles: optimization via Box-Behnken design response surface methodology and physicochemical characterization. Curr Drug Deliv . 2017;14(5):676-89.
Kassem M, El Shaboury K, Mohamed A. Application of central composite design for the development and evaluation of chitosan-based colon targeted microspheres and in vitro characterization. Indian J Pharm Sci . 2019;81(2):354-64.
Kazmi SR, Jun R, Yu MS, Jung C, Na D. In silico approaches and tools for the prediction of drug metabolism and fate: A review. Comput Biol Med. 2019;106:54-64.
Koradia K, Parikh R, Koradia D. Application of plackett and burman design for screenin g of factors affecting albendazole nanocrystals. Curr Nanomed. 2017;7(2):158-67.
Kyavars V, Subramanian S. Formulation development and characterization of dasatinib nanocrystals and optimization using response surface methodology. Int J Pharma Res Health Sci. 2018;6(1):2295-02.
Lee M, Choi M. The determinants of research and development investment in the pharmaceutical industry: focus on financial structures. Osong Public Health Res Perspect. 2015;6(5):302-9.
Lennox D. X-Ray Powder Diffraction Patterns of Some Organic Compounds. Anal Chem. 1957;29(10):1433-5.
Mishra N, Mishra M, Padh H. Formulation development and optimization of efavirenz loaded SLNs and NLCs using Plackett- Burman design and its statistical elucidation. Int J Pharma Res Health Sci . 2018;6(2):2379-88.
Onakpoya IJ, Heneghan CJ, Aronson JK. Delays in the post- marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis. BMC Med. 2015;13:26.
Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med . 2016;14:10.
Ooms F. Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry. Curr Med Chem. 2000;7(2):141-58.
Osamura T, Takeuchi Y, Onodera R, Kitamura M, Takahashi Y, Tahara K, et al. Formulation design of granules prepared by wet granulation method using a multi-functional single- punch tablet press to avoid tableting failures. Asian J Pharm Sci . 2018;13(2):113-9.
Parhi R, Suresh P, Patnaik S. Application of response surface methodology for design and optimization of reservoir- type transdermal patch of simvastatin. Curr Drug Deliv . 2016;13(5):742-53.
Prasad PS, Imam SS, Aqil M, Sultana Y, Ali A. QbD- based carbopol transgel formulation: characterization, pharmacokinetic assessment and therapeutic efficacy in diabetes. Drug Deliv. 2016;23(3):1047-56.
Qu X, Venter G, Haftka R. New formulation of minimum- bias central composite experimental design and Gauss quadrature. Struct Multidiscipl Optim. 2004;28(4):231-42.
Rezende CA, Atta BW, Breitkreitz MC, Simister R, Gomez LD, McQueen-Mason SJ. Optimization of biomass pretreatments using fractional factorial experimental design. Biotechnol Biofuels. 2018;11:206.
Roy H, Nandi S. In-Silico Modeling in Drug Metabolism and Interaction: Current Strategies of Lead Discovery. Curr Pharm Des. 2019;25(31):3292-305.
Roy H. Box-Behnken Design for Optimization of Formulation Variables for Fast Dissolving Tablet of Urapidil. Asian J Pharm. 2018;12(3):S946-S954.
Sadhukhan B, Mondal NK, Chattoraj S. Optimisation using central composite design (CCD) and the desirability function for sorption of methylene blue from aqueous solution onto Lemna major. Karbala Int J Mod Sci. 2016;2(3):145-55.
Saini N, Bakshi S, Sharma S. In-silico approach for drug induced liver injury prediction: Recent advances. Toxicol Lett. 2018;295:288-95.
Sathish T, Kezia D, Bramhachari PV, Prakasham RS. Multi- objective based superimposed optimization method for enhancement of l-glutaminase production by Bacillus subtilis RSP-GLU. Karbala Int J Mod Sci . 2018;4(2018):50-60.
Shamsi M, Mohammadi A, Manshadi MK, Sanati-Nezhad A. Mathematical and computational modeling of nano- engineered drug delivery systems. J Control Release. 2019;307:150-65.
Simionato LD, Petrone L, Baldut M, Bonafede SL, Segall AI. Comparison between the dissolution profiles of nine meloxicam tablet brands commercially available in Buenos Aires, Argentina. Saudi Pharm J. 2018;26(4):578-84.
US National library of medicine. Pubchem: Stavudine. Available from: Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Stavudine [cited 2019 August 30].
» https://pubchem.ncbi.nlm.nih.gov/compound/Stavudine
Using METHOCEL cellulose ethers for controlled release of drugs in hydrophilic matrix systems. Available from: Available from: https://www.colorcon.com/cn/products-formulation/all-products/download/677/2554/34 [cited 2019 August 12].
» https://www.colorcon.com/cn/products-formulation/all-products/download/677/2554/34
World Health Organization. HIV AIDS: Key facts. Available from: Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids [cited 2019 September 18].
» https://www.who.int/news-room/fact-sheets/detail/hiv-aids
Yu XQ, Wilson AG. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development. Future Med Chem. 2010;2(6):923-8.
Zerit (Stavudine). Available from: Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20412S017.pdf [cited 2021 April 1].
» https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20412S017.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
